We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Preventing Cancer without Harming Cells

By Biotechdaily staff writers
Posted on 09 Apr 2007
Initiating senescence in aged cells may be enough to protect against spontaneous cancer development, according to new research.

It was previously unknown whether cellular senescence or programmed cell death (apoptosis) was the more critical safeguard mechanism for suppressing tumors arising from dysfunctional telomeres. More...
Aged cells have abnormal chromosomes with dysfunctional telomeres (shorter ends) that can induce tumorigenesis in the absence of the tumor suppressor p53, and may be related to the higher rate of cancer in older individuals. However, in the presence of p53, dysfunctional telomeres can induce a permanent arrest of cell growth, known as senescence.

Dr. Sandy Chang and colleagues, from M.D. Anderson Cancer Center (Houston, TX, USA), examined mutant mice with dysfunctional telomeres and copies of the p53 gene that cannot initiate p53-dependent apoptosis but can carry out p53-mediated senescence.

The investigators discovered that triggering the senescence pathway was sufficient to suppress spontaneous tumorigenesis. Their findings suggest that, by stopping cellular proliferation, p53-mediated senescence may act as an important tumor suppressor mechanism in aged cells.
The study was published online March 30, 2007, in the journal EMBO (European Molecular Biology Organization).


Related Links:
M.D. Anderson Cancer Center

New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Chromogenic Culture System
InTray™ COLOREX™ ECC
New
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Plasma pTau217 testing can predict future amyloid accumulation and cognitive decline in cognitively healthy older adults (photo courtesy of Shutterstock)

Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more

Industry

view channel
Image: Pathlight combines WGS and dPCR to identify and longitudinally track large‑scale genomic changes, known as structural variants (photo courtesy of SAGA Diagnositcs)

Roche Affiliate Expands MRD Portfolio with SAGA Acquisition

Foundation Medicine, Inc., an independent affiliate of Roche, announced plans to expand its monitoring portfolio with SAGA Diagnostics’ Pathlight, a personalized, tumor-informed molecular residual disease... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.